Life sciences · Journal article
Journal of Modern Medicine · September 24, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The article examines the association between menopausal hormone therapy and the risk of breast cancer in postmenopausal women. Current evidence concerning the effects of estrogens and progestogens on hormone-dependent processes in breast tissue is reviewed. Particular attention is paid to differences between estrogen-only therapy and combined estrogen-progestogen therapy, as well as to treatment duration, age at initiation and the interval between menopause and the start of therapy. Factors that may modify individual breast cancer risk, including hereditary predisposition, excess body weight, reproductive history, breast density and concomitant diseases, are considered. The effect of menopausal hormone therapy on breast cancer risk is shown to vary according to the hormonal regimen and duration of exposure. The importance of an individualized assessment of potential benefits and risks before treatment initiation and regular breast surveillance during therapy is emphasized. A personalized approach to menopausal hormone therapy is considered essential for improving treatment safety and selecting the most appropriate management strategy for postmenopausal women.